Navigation Links
The greatest life-science developments of 2004

What have been the greatest developments in life sciences for 2004 and what impact will these have on the future? While a lot of things have happened in 2004 in the land of biotech and pharmaceuticals, the answer could be:

1. Mercks taking Vioxx off the market due to potent cardiovascular side effects and the resultant scrutiny on the ......

Full article >>> t and device business. Guidant fit that bill. Via acquisitions, Johnson & Johnson has rapidly built an increasingly strong place in the industry to hedge its bets on both drugs (Pfizer) and medical devices (Medtronic).

3. The mergers of four Japanese companies this year. Anyone who has studied the Japanese knows that mergers between Japanese companies are not only not common......

Full article >>> armaceutical Executive December 2004 edition (called Unleashing the Dragon by Zhu Shen) made me think even more about China.

Look at some of the data supporting China becoming a major force in life sciences (according to Pharmaceutical Executive):

Pharmaceutical Market:
  • China is currently the seventh-largest health-care market in the world.
  • By 20......

    Full article >>> . This company expects to increase its sales force to 900 people in China. Also, this company opened an East Asia clinical trial center in Shanghai.
  • Novartis has invested about $70 million in China and has annual sales of about $120 million.
  • Roche opened an R&D center in Shanghai, which is its first in Asia and fifth worldwide.
  • Eli Lilly also opened up an R&D facility in Sh......

    Full article >>> rsities and top research institutions. By the way, the Shanghai Zhangjiang Hi-Tech Park includes both facilities for Roche and Eli Lilly.

    Intellectual Property Protection:
  • This has been an area of major concern to American and European pharmaceutical companies. Before 1993, China didnt grant drug patents. China was granted entry into the World Trade Organization in 2001. Th......

    Full article >>> General Motors had a profit of $437 million in 2003 in its Chinese operations, which was more than 50 percent of its entire North American profits.

    Intel generated revenues of $3.7 billion from China in 2003 and China became the third-largest market for this company and one of its most profitable markets. Intel has invested in start-up technology companies in China and currently has vent......

    Full article >>> ut of the University of Illinois at Chicago developing cancer vaccines. Rosen is also a founder and board member at the Illinois Biotechnology Industry Organization (IBIO). He can be reached at rosenmichaels@aol.com.

  • This article has been syndicated on the Wisconsin Technology Network courtesy o......

    Full article >>>
    '"/>


    Source:wistechnology.com By Michael Rosen 12/21/04


    Related biology technology :

    1. Historic lists - The greatest rock bands, rock guitarists of all time
    2. A Midwest life-science odyssey comes full circle
    3. A Midwest small-cap, life-science surprise package
    4. Madison life-science firms agree to co-develop kidney product
    5. Does Milwaukee need a life-science spark?
    6. The top 10 misconceptions of life-science patents
    7. British, Wisconsin firms explore life-science opportunities together
    8. Midwest large-cap life-science sector is solid in first quarter
    9. Bio-Logic Systems, another Midwest life-science firm, flies under the radar
    10. Midwest life-science company Perrigo globalizes under the radar
    11. Recent developments in the protection of trademarks on the Internet
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
    (Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
    (Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
    (Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
    Breaking Biology Technology:
    (Date:8/15/2017)... ivWatch LLC , a medical device company focused on improving the ... its ISO 13485 Certification, the global standard for medical device quality ... ... device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates ...
    (Date:5/23/2017)... the first robotic gym for the rehabilitation and functional motor sense evaluation ... Genoa, Italy . The first 30 robots will be available from ... . The technology was developed and patented at the IIT laboratories ... Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
    (Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
    Breaking Biology News(10 mins):